60637-97-0 Usage
Uses
Used in Organic Synthesis:
2-Cyclobutylethylamine is utilized as a building block in organic synthesis for the creation of a variety of organic compounds. Its cyclobutyl group and amine functionality contribute to the structural diversity and reactivity of the molecules it helps to form.
Used in Pharmaceutical Research:
In pharmaceutical research, 2-Cyclobutylethylamine serves as a key intermediate in the development of new drugs. Its unique structure allows it to be incorporated into medicinal compounds, potentially enhancing their therapeutic effects or modifying their pharmacokinetic properties.
Used in Medicinal Chemistry:
2-Cyclobutylethylamine is employed in medicinal chemistry for the design and synthesis of novel bioactive molecules. Its cyclobutylethylamine moiety can be a crucial component in the development of drugs with specific targeting or binding properties.
Used in Drug Development:
Due to its reactivity and structural attributes, 2-Cyclobutylethylamine may have potential uses in drug development, where it can be explored for its capacity to improve the efficacy, selectivity, or safety profile of new pharmaceutical agents.
Check Digit Verification of cas no
The CAS Registry Mumber 60637-97-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,0,6,3 and 7 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 60637-97:
(7*6)+(6*0)+(5*6)+(4*3)+(3*7)+(2*9)+(1*7)=130
130 % 10 = 0
So 60637-97-0 is a valid CAS Registry Number.
60637-97-0Relevant academic research and scientific papers
Piperazine derivatives and their use as therapeutic agents
-
, (2016/03/19)
Compounds for treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the compounds are of formula (I): where x y, W, V, R 2 , R 3 , R 4 , R 5 , R 6 , R 6a , R 7 , R 7a , R 8 , R 8a , R 9 and R 9a are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.
AMIDE DERIVATIVES AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS
-
Page/Page column 59-60, (2015/03/13)
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, formula (I) wherein R1. X, m. R2, Y, R3, Z, n, R4. A and B are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
PYRAZOLINES AS PAR-1 ANTAGONISTS FOR TREATMENT OF CARDIOVASCULAR DISEASES
-
Page/Page column 51, (2010/02/10)
The invention relates to pyrazolines of formula (I), where E = methylene, NH, O or S and R2 = a group of formula (II), methods for the production and use thereof for the production of medicaments for the treatment and/or prophylaxis of diseases, in particular, cardiovascular diseases, such as thromboembolitic diseases.
